Bioxytran, Inc (BIXT): Total Assets
$658.6K
As of 2025-12-31
$333.4K
As of 2026-06-30
+21.1%
3-year compound annual growth
+15.1%
5-year compound annual growth
+28.0%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $658.6K | +374.8% | 2026-04-15, Balance as of period end |
| 2024-12-31 | $138.7K | -0.5% | 2026-04-15, Balance as of period end |
| 2023-12-31 | $139.4K | -62.4% | 2025-04-03, Balance as of period end |
| 2022-12-31 | $370.9K | +211.0% | 2025-01-13, Balance as of period end |
| 2021-12-31 | $119.3K | -63.5% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $326.4K | +48.6% | 2022-04-11, Balance as of period end |
| 2019-12-31 | $219.6K | +503.2% | 2021-04-09, Balance as of period end |
| 2018-12-31 | $36.4K | n/m | 2020-03-18, Balance as of period end |
| 2017-12-31 | $110 | -99.8% | 2019-03-13, Balance as of period end |
| 2016-12-31 | $51.7K | -7.4% | 2018-04-02, Balance as of period end |
| 2015-12-31 | $55.8K | -50.7% | 2017-03-31, Balance as of period end |
| 2014-12-31 | $113.3K | -56.2% | 2016-09-20, Balance as of period end |
| 2013-12-31 | $258.4K | -39.7% | 2015-04-10, Balance as of period end |
| 2012-12-31 | $428.4K | +98.3% | 2014-04-14, Balance as of period end |
| 2011-12-31 | $216.1K | +167.7% | 2013-04-15, Balance as of period end |
| 2010-12-31 | $80.7K | n/a | 2012-12-31, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Bioxytran, Inc (BIXT) | 2025-12-31 | $658.6K | +374.8% |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | $697.5K | -30.7% |
| ProtoKinetix, Inc. (PKTX) | 2025-12-31 | $483.4K | +3.7% |
| Ocean Biomedical, Inc. (OCEA) | 2024-12-31 | $902.0K | -83.6% |
| Bio Essence Corp (BIOE) | 2025-12-31 | $422.5K | +50.3% |
| NeuroSense Therapeutics Ltd. (NRSN) | 2025-12-31 | $1.03M | -77.5% |
| Polomar Health Services, Inc. (PMHS) | 2025-12-31 | $390.0K | -96.1% |
| Bespoke Extracts, Inc. (BSPK) | 2024-12-31 | $359.1K | +1.3% |
| ZyVersa Therapeutics, Inc. (ZVSA) | 2025-12-31 | $347.9K | -98.3% |
Compare BIXT, PVCT, PKTX, OCEA side by side · Screen every company in Pharmaceutical Preparations ↗